Eurostarsprojekt, E! 9215 IMAID Redoxis AB
| Reference number | |
| Coordinator | Redoxis AB - Redoxis AB, Lund |
| Funding from Vinnova | SEK 3 321 556 |
| Project duration | April 2015 - March 2018 |
| Status | Completed |
| Venture | Eurostars |
| Call | Eurostars medfinansiering 2014-2015 |
Important results from the project
The aim of this program was to develop a service for evaluation of effects of inflammatory disease in preclinical models of autoimmune disease. We have during the program, efficiently evaluated and standardized procedures and developed a service that is now being marketed to customers, well in line with the goal of the program.
Expected long term effects
We have developed a marketable service that are now being presented to potential customers.
Approach and implementation
The program has been advancing well with one delay due to exchange of MRI equipment. All planned experiments and analyses have been performed and reports have been prepared.